At TLC, we develop novel nanomedicines that maximize the potential of our lipid-based drug delivery technologies. We are currently focused on creating new therapies in the areas of oncology, ophthalmology and osteoarthritis.
4D Molecular Therapeutics
8 followers
Dyne Therapeutics
6 followers
BlueRock Therapeutics
3 followers
Arcutis Biotherapeutics
3 followers
Rhythm Pharmaceuticals
5 followers
Menarini Silicon Biosystems
1 follower
Manus Bio
1 follower
Zageno
1 follower
FogPharma
1 follower
Sanofi
475 followers
Thermo Fisher Scientific
284 followers
Gilead Sciences
213 followers